|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
Epidemiology: Inflammatory Bowel Disease - Stable incidence but high prevalence due to early diagnosis and improved survival Price: $5,700.00 (€4,462.92) ($6,840.00 (€5,355.51) Including VAT at 20%)
|
| Publication Date: 25-Mar-2011 Please click here for more information or to purchase this report at our partner store
This module provides an overview of inflammatory bowel disease (Crohns Disease and ulcerative colitis) in the seven major markets. |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
Pipeline Insight: Inflammatory Bowel Disease - Varied drug targets to broaden future therapy options Price: $11,400.00 (€8,925.85) ($13,680.00 (€10,711.02) Including VAT at 20%)
|
| Publication Date: 06-Jul-2010 Please click here for more information or to purchase this report at our partner store
Overview of the inflammatory bowel disease pipeline, with drug assessments and sales-based forecast of key late-stage pipeline candidates. Datamonitor also provides epidemiology information and forecasts, unmet needs and opinion leader insight. |
|
 |
Inflammatory Bowel Disease Market Forecast Price: $15,200.00 (€11,901.13) ($18,240.00 (€14,281.35) Including VAT at 20%)
|
| Publication Date: 05-Aug-2010 Please click here for more information or to purchase this report at our partner store
Analysis of the current and future inflammatory bowel disease market with indication-specific sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) for key marketed brands |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |